Best Carb Blocker .com

Manasquan, NJ (PRWEB) January 16, 2008

Remember a time, several years ago, when it appeared like everyone you cognized was misplacing weight with one ad hoc, much-celebrated weight-loss formulation? Those were breathless days, filled up with the promise of tangible and spectacular animal transformations. Now the company that established that first blessed age of thermogenic weight loss, Cytodyne Technologies (a division of NutraQuest Inc), and that brand, Xenadrine, have returned to the limelight with several authorised announcements that have shook the diet supplement industry and animated fresh hope in the hearts of fitness-conscious Americans everywhere

First and foremost, Cytodyne Technologies has emerged from a self-imposed five-year hiatus from the retail marketplace. However, the team was certainly not breathing during this time. To the antonymous, they were consecrating their time to working with top researchers on the intense technological investigation into fresh technologies projected to alleviate high-impact thermogenesis and weight loss. Those inquiries have gave way several innovative new weight-loss technologies and compounds, and Cytodyne is now braced to re-enter the diet supplement retail marketplace in a very high-profile way.

Secondly, and perhaps even more importantly, Cytodyne is introducing a cutting-edge fresh version of its flagship Xenadrine-EFX product which will be named Ultra-Strength Xenadrine-EFX. This new version contains an incomparable altered compound that provides an appended dimension of muscular weight-loss efficacy that goes beyond anything previously accessible in the EFX product line

“This is a thrilling time for us and for our many millions of loyal customers,” Cytodyne founder and president Bob Chinery says. “People thought we were gone, but the truth was the exact opposite. In fact, we were centring on research and development without the distractions of commercializing and retailing. We put together an elite research team headed up by a known medical doctor and two leading university researchers and set them to work on a number of entirely fresh paths of technological investigation regarding thermogenesis, abdominous loss, and energy production.”

Cytodyne’s five-year program of concentrated focus on research and development represents an immoderate departure from characteristic business protocol in the supplement industry. “Chinery has always been a fanatic about the arduous science end of this business,” says Cytodyne Director of Sales, Kelly Conklin. “I retrieve May of 2003, when he stated we were traveling to license the brand to another company and focus exclusively on what we do best, evolving innovative fresh products. I was balled over. We were far and away the #1 trading brand in the industry at that time. Any other company would have just glided along and overworked the sales latent, but not Cytodyne. The standards for Chinery and his research team are so eminent that they desired the ability to focus completely on the product development end of the business while others covered with commercializing and selling.    Chinery and his research team basically opened up contemporary weight-loss supplementation with Xenadrine RFA-1 over a decade ago, and are now setting out to do the same thing a second time with this latest widened period of research, development, and testing. Now that I see how far ahead of the industry we are on the science end, it all makes sense. It would have been next to hopeless to accomplish these technological developments while simultaneously pulling off the distractions of the sales and marketing end of the business.

“I look back at the last five years, and we probably lost plenty of potential revenue. On the other hand, with a solid bedrock of nearly five years’ worth of cutting-edge research, data, and analysis by the top experts in the weight-loss field, plus some really exciting products on the verge of being released, it’s clear that all the effort was worthwhile. With the innovations that have come out of this arduous work, we are now braced to make up that lost ground and then some. But that’s Chinery. He’s all about innovation, quality control, and technological integrity. So many companies in this business are about tomorrow’s sales numbers, but Chinery has always stressed the importance of awful product quality as the foundation first and foremost. His philosophy has always been that if your product is truly conspicuous, the sales will quickly postdate.”

Indeed, industry buzz has been building about the first of those products out of the pipeline, Ultra-Strength Xenadrine-EFX. Cytodyne has been keeping an air-tight rein on information about its freshest product establish, but advance word on the freshly altered weight-loss compound that functions as the cornerstone weight-loss agent in the fresh formulation has been overwhelmingly plus. And then there’s the industry-wide mouthing about an even more significant better thermogenic breakthrough on the horizon for later this year. No one tied in with Cytodyne would render any specifics, though Kelly Conklin was consenting to acknowledge, “That product is traveling to change the industry the way Xenadrine RFA-1 did in 1998.”    

Meanwhile, vying manufacturers who have capitalized on Cytodyne’s retailing pullback in modern years are understandably excitable. “Oh, yeah, they retrieve what happened last time,” says Cytodyne Chief Scientific Advisor Jeff Volek. “Xenadrine RFA-1 predominated the industry. Everyone from elite athletes to housewives were utilizing it and getting alarming weight-loss results. Xenadrine RFA-1 set up benchmarks that other companies in this industry still haven’t corresponded. It went through the strictest nonsubjective tests universities and autonomous research facilities could subject it to. It even outperformed the prescription weight-loss drug Xenical® in a head-to-head clinical test. Now that the avant-garde Cytodyne team is back in the marketplace, these other companies may be appearing at some anorectic years ahead.”    

For right now, though, the original Cytodyne team is just happy to be back in a position where they can reach out to their devoted customers and return to the business of helping them achieve their fitness goals.

“At heart, we’re research and development guys first and foremost,” Chinery says. “But after five years of aggravated research and development, it’s traveling to be fun to get out into the marketplace, introduce some products we’re genuinely arrogant of, and go toe-to-toe with some of the hype-driven competition.”

###